Пресс-релизы
Nov
Oct
Sep
- Dr. Reddy's Annual Report on Form 20-F for year ended March 31, 2007 available on the company's website
- Dr. Reddy's commences operations in Philippines. Expands presence in the ASEAN region
- Dr. Reddy's receives USFDA approval for Ranitidine (Zantac™) Tablets, 150mg (OTC)
- Dr. Reddy's enters the Dermatology topical anti-fungal market with the launch of 'EbernetTM' - (Eberconazole)
Jul
Jun
May
Apr
- Dr. Reddy’s announces new R&D Chief
- Dr. Reddy's launches Reditux™ - Monoclonal Antibody Treatment for Non-Hodgkin's Lymphoma
- Dr. Reddy's announces the launch of Zolpidem Tartrate tablets
- Dr. Reddy's employees awarded PG certificates from BITS Pilani
- Dr. Reddy's is the First Participant in United States Pharmacopoeia's New Pharmaceutical Ingredient Verification Programme